Search

Search Constraints

You searched for: Author/Creator Solas, Caroline

Search Results

1. Addition of boceprevir to PEG-interferon/ribavirin in HIV-HCV-Genotype-1-coinfected, treatment-experienced patients: efficacy, safety, and pharmacokinetics data from the ANRS HC27 study. Issue 2 (3rd March 2016)

3. Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV. (23rd January 2023)

4. Daclatasvir Plasma Concentration Assessment in HIV–HCV-Coinfected Real-Life Patients. Issue 8 (November 2017)

6. EPCT-11. PHASE 1 STUDY OF FLUVASTATIN-CELECOXIB COMBINATION IN CHILDREN WITH RELAPSING/REFRACTORY OPTICO-CHIASMATIC LOW-GRADE GLIOMA OR HIGH-GRADE GLIOMAS (FLUVABREX): FINAL RESULTS. (4th December 2020)

7. Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV–hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy. (24th August 2016)

8. Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV–hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy. (24th August 2016)

9. Hepatitis C virus NS3 protease genotyping and drug concentration determination during triple therapy with telaprevir or boceprevir for chronic infection with genotype 1 viruses, southeastern France. Issue 11 (23rd July 2014)

10. Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection. Issue 8 (26th August 2020)